Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity
eLife · 16.04.2025 · 13
DOI: 10.7554/elife.95347 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 16.04.2025. Verfasst von Hirokazu Kimura und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, the Johns Hopkins University School of Medicine, Baltimore, United States. Hauptthemen laut MEDLINE: Mutation, Missense, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Japanese Society of Gastroenterology, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Interpretation of variants identified during genetic testing is a significant clinical challenge. In this study, we developed a high-throughput CDKN2A functional assay and characterized all possible human CDKN2A missense variants. We found that 17.7% of all missense variants were functionally deleterious. We also used our functional classifications to assess the performance of in silico models that predict the effect of variants, including recently reported models based on machine learning. Notably, we found that all in silico models performed similarly when compared to our functional classifications with accuracies of 39.5–85.4%. Furthermore, while we found that functionally deleterious variants were enriched within ankyrin repeats, we did not identify any residues where all missense variants were functionally deleterious. Our functional classifications are a resource to aid the interpretation of CDKN2A variants and have important implications for the application of variant interpretation guidelines, particularly the use of in silico models for clinical variant interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, the Johns Hopkins University School of Medicine, Baltimore, United States.
- Division of Integrated Genomics, Translational Genomics Research Institute, Phoenix, United States.
- Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, United States.
- Department of Oncology, the Johns Hopkins University School of Medicine, Baltimore, United States.
ORCID-Profile: Nicholas Jason Roberts
Förderung
- NCI NIH HHS
- Japanese Society of Gastroenterology
- Japan Society for the Promotion of Science
- National Cancer Institute
- Susan Wojcicki and Dennis Troper
- The Sol Goldman Pancreatic Cancer Research Center
- Rolfe Pancreatic Cancer Foundation
Zitieren
APA
Kimura, H., Lahouel, K., Tomasetti, C., & Roberts, N. J. (2025). Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity. eLife, 13. https://doi.org/10.7554/elife.95347
Vancouver
Kimura H, Lahouel K, Tomasetti C, Roberts NJ. Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity. eLife. 2025;13. doi:10.7554/elife.95347
BibTeX
@article{Kimura2025,
author = {Kimura, Hirokazu and Lahouel, Kamel and Tomasetti, Cristian and Roberts, Nicholas Jason},
title = {Functional characterization of all CDKN2A missense variants and comparison to in silico models of pathogenicity},
journal = {eLife},
year = {2025},
volume = {13},
doi = {10.7554/elife.95347}
}
EUVIMED